These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 7904048)
1. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo. Sharp T; McQuade R; Bramwell S; Hjorth S Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048 [TBL] [Abstract][Full Text] [Related]
2. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo. Sharp T; McQuade R; Fozard JR; Hoyer D Br J Pharmacol; 1993 Jul; 109(3):699-702. PubMed ID: 8102935 [TBL] [Abstract][Full Text] [Related]
3. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. Hjorth S; Sharp T J Pharmacol Exp Ther; 1993 May; 265(2):707-12. PubMed ID: 8098761 [TBL] [Abstract][Full Text] [Related]
4. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Sharp T; Bramwell SR; Grahame-Smith DG Br J Pharmacol; 1989 Feb; 96(2):283-90. PubMed ID: 2466516 [TBL] [Abstract][Full Text] [Related]
6. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat. Schreiber R; De Vry J Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566 [TBL] [Abstract][Full Text] [Related]
7. Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe. Dong J; de Montigny C; Blier P Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):303-11. PubMed ID: 9303566 [TBL] [Abstract][Full Text] [Related]
8. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378. Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304 [TBL] [Abstract][Full Text] [Related]
9. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo. Hjorth S; Pettersson G Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622 [TBL] [Abstract][Full Text] [Related]
10. Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study. Routledge C; Gurling J; Wright IK; Dourish CT Eur J Pharmacol; 1993 Aug; 239(1-3):195-202. PubMed ID: 8223894 [TBL] [Abstract][Full Text] [Related]
11. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Meller E; Goldstein M; Bohmaker K Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223 [TBL] [Abstract][Full Text] [Related]
12. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse. Dursun SM; Handley SL Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640 [TBL] [Abstract][Full Text] [Related]
13. Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone. Monti JM; Jantos H; Silveira R; Reyes-Parada M; Scorza C Pharmacol Biochem Behav; 1995 Oct; 52(2):305-12. PubMed ID: 8577795 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066 [TBL] [Abstract][Full Text] [Related]
15. (-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors. Assie MB; Koek W Neuropharmacology; 1996 Feb; 35(2):213-22. PubMed ID: 8734491 [TBL] [Abstract][Full Text] [Related]
16. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study. Hjorth S; Sharp T; Liu Y Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced defaecation in rats: role of central 5-HT1A receptors. Croci T; Landi M; Bianchetti A; Manara L Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978 [TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex. Liu YP; Wilkinson LS; Robbins TW Psychopharmacology (Berl); 2004 Apr; 173(1-2):175-85. PubMed ID: 14726995 [TBL] [Abstract][Full Text] [Related]
19. Effects of buspirone and ipsapirone on schedule induced polydipsia: comparison with 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and raclopride. Ryan CN; Evenden JL; Petterson M Psychopharmacology (Berl); 1993; 112(1):34-44. PubMed ID: 7871008 [TBL] [Abstract][Full Text] [Related]
20. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor. Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]